FDAnews Drug Daily Bulletin

Bristol-Myers, AstraZeneca Expand Diabetes Alliance

Aug. 13, 2012
A A
Bristol-Myers Squibb Company and AstraZeneca have announced the completion of the acquisition of Amylin Pharmaceuticals by Bristol-Myers Squibb.
Pharmaceutical Business Review